[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-359719-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-359719-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","folate-promotes-colorectal-cancer-progression-by-impairing-cd8-t-cell-function-and-recruitment-via-slc19a1p-aktnotch1-axis-and-ccl5-downregulation","Folate promotes colorectal cancer progression by impairing CD8+ T cell function and recruitment via SLC19A1/p-AKT/NOTCH1 axis and CCL5 downregulation","","Folate supplementation promotes colorectal cancer growth and promotes immune evasion by inducing functional exhaustion of cytotoxic CD8+ T cells. Using subcutaneous and orthotopic CRC mouse models, the study evaluates CD8+ T-cell function and recruitment through flow cytometry, histology, imaging, migration assays, RNA sequencing, and ChIP-qPCR. Mechanistically, folate increases SLC19A1/RFC1 expression via AKT phosphorylation, activating NOTCH1 signaling and exhaustion, while suppressing CCL5 transcription by downregulating PBX3 in CRC cells. Dietary folate restriction enhances tumor control and synergizes with anti-PD-1 therapy, in a preclinical setting.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/folate-promotes-colorectal-cancer-progression-by-impairing-cd8-t-cell-function-and-recruitment-via-slc19a1p-aktnotch1-axis-and-ccl5-downregulation/359719/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/folate-promotes-colorectal-cancer-progression-by-impairing-cd8-t-cell-function-and-recruitment-via-slc19a1p-aktnotch1-axis-and-ccl5-downregulation/359719.png","ImageObject",300,407,{"name":42,"@type":43},"Alex Sinclair","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does folate affect colorectal cancer progression in the study?","Question",{"text":63,"@type":64},"Folate supplementation significantly promotes CRC growth and enhances immune evasion by impairing CD8+ T-cell anti-tumor activity. It accelerates progression in preclinical mouse models.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What molecular pathway links folate to CD8+ T cell exhaustion?",{"text":68,"@type":64},"Folate enhances SLC19A1 (RFC1) expression through increased AKT phosphorylation. Activated AKT stimulates downstream NOTCH1 signaling, driving a CD8+ T-cell exhaustion phenotype.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the tumor microenvironment contribute to folate-driven immune evasion?",{"text":72,"@type":64},"In the CRC tumor microenvironment, folate suppresses PBX3 expression in tumor cells. This reduces CCL5 transcription, which impedes CD8+ T cell recruitment.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},359719,1790177457,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Qing et al. Journal of Translational Medicine (2026) 24:563  \n[https://doi.org/10.1186/s12967-026-07993-7](https://doi.org/10.1186/s12967-026-07993-7)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nFolate promotes colorectal cancer   \nprogression by impairing CD8+ T cell function and recruitment via SLC19A1/p-AKT/NOTCH1 axis and CCL5 downregulation  \nShunjie Qing1,3†, Yunyan Ling2†, Yingjie Lai2†, Yating Hu1,3†, Yi Zhong1,3, Yuechen Liu1,3, Xiang Liu1,3, Yuan Fang2, Junying Qian2, Haijun Deng1,3, Yifeng Peng1,4*, Dehua Wu2* and Zhiyong Shen1,3*  \nAbstract  \nBackground Dietary factors have been recognised as contributors to the etiology of colorectal cancer (CRC) . Folate is a micronutrient of critical importance to human health, frequently utilized as a dietary supplement. Previous clinical evidence suggested that folate intake is associated with an increased risk of CRC. However, the underlying mechanisms remain unclear. Here, we report that folate supplementation significantly promotes CRC growth and is associated with functional exhaustion of cytotoxic CD8+ T cell to enhance immune evasion.  \nMethods Using subcutaneous and orthotopic colorectal cancer mouse models, we investigated the impact of folate on CRC progression. Flow cytometry, immunohistochemistry, immunofluorescence, Transwell assays, RNA sequencing, and ChIP-qPCR were employed to elucidate the role and underlying mechanisms of folate in modulating CD8+ T cell function and recruitment within the tumor. By integrating dietary folate restriction with PD-1 monoclonal antibody therapy in subcutaneous tumor models, we further explored its effects in a preclinical setting.  \nResults Our study indicates that folate directly impairs cytotoxic CD8+ T cell function and promotes immune escape, thereby accelerating colorectal cancer progression. Mechanistically, folate enhances the expression of SLC19A1, which encodes the folate transporter RFC1, by promoting AKT phosphorylation. Elevated AKT phosphorylation activates the downstream NOTCH1 signaling pathway, leading to aT cell exhaustion phenotype. Meanwhile, folate in the tumor microenvironment suppresses PBX3 expression in CRC cells, thereby reducing CCL5 transcription and impeding CD8+  \n†Shunjie Qing, Yunyan Ling, Yingjie Lai andYating Hu contributed equally to this work.  \n*Correspondence: Yifeng Peng [546599540@qq.com](546599540@qq.com)[ ](546599540@qq.com)Dehua Wu [18602062748@163.com](18602062748@163.com)[ ](18602062748@163.com)Zhiyong Shen [szy2728@163.com](szy2728@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nQing et al. Journal of Translational Medicine (2026) 24:563 Page 2 of 22  \nT cell recruitment. Furthermore, in vivo dietary folate restriction enhances tumor control and synergizes with anti-PD-1 immunotherapy in CRC.  \nConclusions Thi","cbCaikS0DcAmhBm4","https://ap.wps.com/l/cbCaikS0DcAmhBm4","pdf",14558459,22,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"How does folate affect colorectal cancer progression in the study?\",\"answer\":\"Folate supplementation significantly promotes CRC growth and enhances immune evasion by impairing CD8+ T-cell anti-tumor activity. It accelerates progression in preclinical mouse models.\"},{\"question\":\"What molecular pathway links folate to CD8+ T cell exhaustion?\",\"answer\":\"Folate enhances SLC19A1 (RFC1) expression through increased AKT phosphorylation. Activated AKT stimulates downstream NOTCH1 signaling, driving a CD8+ T-cell exhaustion phenotype.\"},{\"question\":\"How does the tumor microenvironment contribute to folate-driven immune evasion?\",\"answer\":\"In the CRC tumor microenvironment, folate suppresses PBX3 expression in tumor cells. This reduces CCL5 transcription, which impedes CD8+ T cell recruitment.\"}]","Folate promotes colorectal cancer progression by impairing CD8+ T cell function and recruitment via SLC19A1/p-AKT/NOTCH1 axis and CCL5 downregulation | PDF",1790137633,55,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ecaa078fff380c6dce0aa37cc30bfd69.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/730b062ccab66ba1640dad2fef56abe1.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3fff3fb9ef5f2f14349c67885c55724.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0fb221c8b04d827320b900ea3abefec6.webp",980,1306]